ACE and myocardial infarction: Several subsequent multicenter clinical trials, using other ACE inhibitors or the newer ARBs, confirmed the initial findings thereby demonstrating their beneficial effects on ventricular remodeling, reduction in the end-stage events of cardiac failure, and repeated myocardial infarction (13).